Literature DB >> 33513179

Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.

Ke Cheng1, Wei Liu1, Jiaying You1, Shashi Shah1, Yunqiang Cai1, Xin Wang1, Bing Peng1.   

Abstract

Currently, safety of laparoscopic pancreaticoduodenectomy (LPD) in patients with liver cirrhosis is unknown. The aim of this study was to explore postoperative morbidity and mortality and long-term outcomes of cirrhotic patients after LPD. The study was a one-center retrospective study comprising 353 patients who underwent LPD between October 2010 and December 2019. A total of 28 patients had liver cirrhosis and were paired with 56 non-cirrhotic counterparts through propensity score matching (PSM). Baseline data, intra-operative data, postoperative data, and survival data were collected. Postoperative morbidity was considered as primary outcome whereas postoperative mortality, surgical parameters (operative durations, intraoperative blood loss), and long-term overall survival were secondary outcomes. Cirrhotic patients showed postoperative complication rates of 82% compared with rates of patients in the control group (48%) (P = 0.003). Further, Clavien-Dindo ≥III complication rates of 14% and 11% (P = 0.634), Clavien-Dindo I-II complication rates of 68% and 38% (P = 0.009), hospital mortality of 4% and 2% (P = 0.613) were observed for cirrhotic patients and non-cirrhotic patients, respectively. In addition, an overall survival rate of 32 months and 34.5 months (P = 0.991), intraoperative blood loss of 300 (200-400) ml and 150 (100-250) ml (P<0.0001), drain amount of 2572.5 (1023.8-5275) ml and 1617.5 (907.5-2700) ml (P = 0.048) were observed in the cirrhotic group and control group, respectively. In conclusion, LPD is associated with increased risk of postoperative morbidity in patients with liver cirrhosis. However, the incidence of Clavien-Dindo ≥III complications and post-operative mortality showed no significant increase. In addition, liver cirrhosis showed no correlation with poor overall survival in patients who underwent LPD. These findings imply that liver cirrhosis patients can routinely be considered for LPD at high volume centers with rigorous selection and management.

Entities:  

Year:  2021        PMID: 33513179      PMCID: PMC7845952          DOI: 10.1371/journal.pone.0246364

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  38 in total

1.  Diagnosis and management of postpancreatectomy hemorrhage: a systematic review and meta-analysis.

Authors:  A Floortje van Oosten; F Jasmijn Smits; Daniël A F van den Heuvel; Hjalmar C van Santvoort; I Quintus Molenaar
Journal:  HPB (Oxford)       Date:  2019-04-06       Impact factor: 3.647

Review 2.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.

Authors:  Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler
Journal:  Surgery       Date:  2016-12-28       Impact factor: 3.982

3.  Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy.

Authors:  Olga Kantor; Mark S Talamonti; Susan Sharpe; Waseem Lutfi; David J Winchester; Kevin K Roggin; David J Bentrem; Richard A Prinz; Marshall S Baker
Journal:  Am J Surg       Date:  2016-12-28       Impact factor: 2.565

4.  Adding Examples to the ASA-Physical Status Classification Improves Correct Assignment to Patients.

Authors:  Erin E Hurwitz; Michelle Simon; Sandhya R Vinta; Charles F Zehm; Sarah M Shabot; Abu Minhajuddin; Amr E Abouleish
Journal:  Anesthesiology       Date:  2017-04       Impact factor: 7.892

5.  Safety of laparoscopic resection for colorectal cancer in patients with liver cirrhosis: A retrospective cohort study.

Authors:  Senjun Zhou; Hepan Zhu; Zhenjun Li; Xiaojiang Ying; Miaojun Xu
Journal:  Int J Surg       Date:  2018-05-26       Impact factor: 6.071

6.  Impact of delayed gastric emptying after pancreaticoduodenectomy on survival.

Authors:  Yasuro Futagawa; Masaru Kanehira; Kenei Furukawa; Hiroaki Kitamura; Seiya Yoshida; Teruyuki Usuba; Takeyuki Misawa; Tomoyoshi Okamoto; Katsuhiko Yanaga
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-07-03       Impact factor: 7.027

7.  Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience.

Authors:  Peter Warnick; Ivo Mai; Fritz Klein; Andreas Andreou; Marcus Bahra; Peter Neuhaus; Matthias Glanemann
Journal:  Pancreatology       Date:  2011-02-18       Impact factor: 3.996

8.  Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy.

Authors:  Ayman El Nakeeb; Ahmad M Sultan; Tarek Salah; Mohamed El Hemaly; Emad Hamdy; Ali Salem; Ahmed Moneer; Rami Said; Ahmed AbuEleneen; Mostafa Abu Zeid; Talaat Abdallah; Mohamed Abdel Wahab
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

9.  Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models.

Authors:  Lichen Xu; Shuangwei Ying; Jianhua Hu; Yunyun Wang; Meifang Yang; Tiantian Ge; Chunhong Huang; Qiaomai Xu; Haihong Zhu; Zhi Chen; Weihang Ma
Journal:  Respir Res       Date:  2018-12-04

10.  Comparison of long-term survival and immediate postoperative liver function after laparoscopic and open distal gastrectomy for early gastric cancer patients with liver cirrhosis.

Authors:  Amer Saeed Alshahrani; Ghung-Sik Gong; Moon-Won Yoo
Journal:  Gastric Cancer       Date:  2016-12-10       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.